1-6 of 6
Sergio Schusterschitz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Azacitidine and Venetoclax in High-Risk Myelodysplastic Syndrome: A Real-World Perspective from the Glam Registry with Long-Term Follow-up

Elia Ixel Apodaca Chavez, Renee Crisp, Ana Laura Varela Constantino, Alicia I Enrico, Andres Gomez-De Leon, Roberto Ovilla-Martínez, Sr., Priscilla Wernicke, Carlos Camargo Molano, Matilde Boada, Elvira D. R. P. Velloso, Sergio Schusterschitz, Laura Kornblihtt, Adriana Karola Puente, Breno Gusmao, Sofia Grille, Fernando Barroso, Carlos Gomez, Martha Alvarado Ibarra, Gabriela Rangel, Marcelo Iastrebner
Journal: Blood
Blood (2024) 144 (Supplement 1): 6718.
https://doi.org/10.1182/blood-2024-209513
Published: 2024
Journal Articles

Safety and efficacy of pegcetacoplan treatment for cold agglutinin disease and warm antibody autoimmune hemolytic anemia

Clinical Trials & Observations
Eloy Roman, Bruno Fattizzo, Merrill Kingman Shum, Wahid T Hanna, Steven R Lentz, Sergio Schusterschitz S Araujo, Mohammed Al-Adhami, Federico V Grossi, Morie A Gertz
Journal: Blood
Blood blood.2023022549.
https://doi.org/10.1182/blood.2023022549
Published: 2024
Includes: Supplemental data
Journal Articles

Myelodysplastic Syndromes in Latin-America - Results from a Novel International Registry: Re-Glam

Sofia Grille, Elvira DRP Velloso, Matilde Boada, Elia Apodaca Chavez, Andres Gomez-De Leon, Anna Cecilia Rodríguez-Zuñiga, Emmanuel Martínez Moreno, Fernando Perez-Jacobo, Graciela Alfonso, Juan Carlos Serrano, Natalia Tejeira, Lilián Díaz, Valentina Olivares, Laura Kornblihtt, Sergio Schusterschitz, Marcelo Iastrebner
Journal: Blood
Blood (2022) 140 (Supplement 1): 4096–4097.
https://doi.org/10.1182/blood-2022-168893
Published: 2022
Journal Articles

Retrospective Observational Study of the Long-Term Safety and Efficacy Outcomes of Rituximab Biosimilar: Partial Data of RTXM83-AC-01-11 Subanalysis Study

Jessika Bridi, Ana Carolina Ferreira Cardoso, Paula Bonilha Fernandes, Maura Gonzaga Lapa, Sergio Schusterschitz, Joao Samuel Farias, Marco Aurelio Salvino, Marcia Higashi, Patricia Giacon, Juliana Pereira, Marcia Delamain, Vivienne Castilho
Journal: Blood
Blood (2022) 140 (Supplement 1): 13236–13238.
https://doi.org/10.1182/blood-2022-167101
Published: 2022
Journal Articles

A Randomized, Double-Blind, Phase III Study Comparing Proposed Biosimilar Rituximab (RTXM83) Versus Reference Rituximab, Both in Combination with CHOP, in the First Line Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Myrna Candelaria, MDPharmD, Derlis Emilio Gonzalez, MD, Surender Kumar Beniwal, MD DM, Lokanatha Dasappa, MD, Daniel Oscar Bar, MD, Marcia Torresan Delamain, Ashis Mukhopadhyay, MD, David Hugo Flores, MD, Dinesh Bhurani, MD DM, FRCPA, Venkatraman Radhakrishnan, MD DM, Alejandro Salvatierra, MD, Ruben Dario Kowalyszyn, MD, Oleg Lipatov, MD, Moosa Patel, MD, Sergio Schusterschitz, MD, Elena Volodicheva, MD, Luis Antonio Perez, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1556.
https://doi.org/10.1182/blood.V130.Suppl_1.1556.1556
Published: 2017
Journal Articles

Results from Hemato-Oncology Latin America Observational Registry (HOLA) Providing Real World Outcomes for the Treatment of Patients with CLL

Carlos Chiattone, MD PhD, David Gomez-Almaguer, MD, Carolina Pavlovsky, MD, Elena Tuna-Aguilar, MD, Ana Lisa Basquiera, MD, Luis Palmer, MD, Danielle Leao Cordeiro De Farias, MD MSc, Sergio Schusterschitz, MD, Kenny Mauricio Galvez, Álvaro Gómez, MD, Telma Santos, MD PhD, Odin De La Mora Estrada, MD
Journal: Blood
Blood (2016) 128 (22): 5578.
https://doi.org/10.1182/blood.V128.22.5578.5578
Published: 2016